Other pipeline products discussed in this round-up include agents for metastatic urothelial cancer, clear cell renal cell carcinoma, and stress urinary incontinence.
Other topics covered in this year's take-home messages for basic science (benign) include interstitial cystitis/bladder pain syndrome and bladder cancer.
"We must better identify patients with higher risk factors for recurrence and follow them more effectively," writes Stephen Y. Nakada, MD.
Many urologists don't follow guidelines calling on them to image their patients after ureteroscopic stone disease treatment, researchers say.
These videos demonstrate significant advances in percutaneous nephrolithotomy technique that can serve to optimize outcomes, reduce OR time, and help achieve optimal results.
The AUA 2018 take-home messages in outcomes also covered topics such as environmental exposures and bladder cancer and onabotulinumtoxinA (Botox) treatment for patients with overactive bladder.
Contrast-enhanced ultrasound for detecting renal cell carcinoma recurrence following ablation and new protocols for low-dose computed tomography in stone patients were among the other research highlights in imaging at the AUA annual meeting.
A mobile app for stone metaphylaxis and an algorithm defining specific indications for stent omissions were among the other highlights in endourology/stones at AUA 2018.
This article discusses the risk of depression and suicide in men, focusing on increased risk in men with genitourinary cancer and other urologic conditions.